
MTIC is the active metabolite of Temozolomide (TMZ). MITC has lower bioavailability in the brain compared with TMZ, because the препарат’s permeability through biological barriers and tumor клетка membranes affects bioavailability. MITC exhibits low affinity to biological membrane.
MTIC is the active metabolite of Temozolomide (TMZ). MITC has lower bioavailability in the brain compared with TMZ, because the drug’s permeability through biological barriers and tumor cell membranes affects bioavailability. MITC exhibits low affinity to biological membrane.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.